---
layout: default
title: Ivabradine Hydrochloride
parent: 僅模型預測 (L5)
nav_order: 66
evidence_level: L5
indication_count: 0
---

# Ivabradine Hydrochloride
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Ivabradine Hydrochloride: Repurposing Evaluation — Insufficient Data to Proceed

## One-Sentence Summary

Ivabradine hydrochloride is a selective If (funny current) inhibitor with established cardiovascular applications in heart rate reduction.
The TxGNN model has **not generated any repurposing predictions** for this compound in the current Evidence Pack, and critical data gaps — including missing DrugBank ID, mechanism of action, and regulatory records — prevent a complete evaluation from being conducted.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Not available in Evidence Pack |
| Predicted New Indication | No predictions generated |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (no clinical evidence; no predictions available) |
| Taiwan Market Status | Not marketed (未上市) |
| Number of Authorizations | 0 |
| Recommended Decision | Hold |

---

## Why No Prediction is Available

Currently, detailed mechanism of action data is not available in this Evidence Pack. Based on the drug name alone, ivabradine hydrochloride is known to be a selective inhibitor of the sinoatrial node If channel, reducing heart rate without affecting myocardial contractility — a mechanism relevant to cardiovascular conditions. However, because no DrugBank ID was resolved and `predicted_indications` is empty, the TxGNN model could not produce repurposing candidates for this compound.

Without predicted indications, there is no repurposing hypothesis to evaluate, and no mechanistic link to a new indication can be reasonably assessed at this stage.

---

## Safety Considerations

Please refer to the SmPC for safety information.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The Evidence Pack for ivabradine hydrochloride contains multiple blocking data gaps — no DrugBank ID, no MOA, no TFDA regulatory records, and most critically, no TxGNN-predicted repurposing candidates. Without a predicted indication, this report cannot fulfill its primary purpose.

**To proceed, the following is needed:**
- Resolve DrugBank ID for ivabradine (or ivabradine hydrochloride as salt form) to enable TxGNN model input
- Re-run TxGNN prediction pipeline once DrugBank ID is confirmed
- Retrieve mechanism of action data from DrugBank API
- Download and parse TFDA package insert (仿單 PDF) to populate safety warnings and contraindications
- Confirm original approved indications from the regulatory source to establish baseline context
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

